Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2013, Article ID 698736, 7 pages
http://dx.doi.org/10.1155/2013/698736
Research Article

Clinical Characteristics of Turkish Women with Candida krusei Vaginitis and Antifungal Susceptibility of the C. krusei Isolates

1Department of Obstetrics and Gynecology, Faculty of Medicine, University of Çukurova, 01330 Adana, Turkey
2Department of Microbiology, Faculty of Medicine, University of Gazi, 06500 Ankara, Turkey
3Department of Microbiology, Faculty of Medicine, University of Erzincan, 24000 Erzincan, Turkey
4Division of Mycology, Department of Microbiology, Faculty of Medicine, University of Çukurova, 01330 Adana, Turkey

Received 30 July 2013; Accepted 4 November 2013

Academic Editor: Harold Wiesenfeld

Copyright © 2013 Ahmet Bariş Güzel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Sobel, “Vulvovaginal candidosis,” The Lancet, vol. 369, no. 9577, pp. 1961–1971, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ilkit and A. B. Guzel, “The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidosis: a mycological perspective,” Critical Reviews in Microbiology, vol. 37, no. 3, pp. 250–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Parazzini, E. Di Cintio, V. Chiantera, and S. Guaschino, “Determinants of different Candida species infections of the genital tract in women,” European Journal of Obstetrics Gynecology & Reproductive Biology, vol. 93, no. 2, pp. 141–145, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. A. B. Guzel, M. Ilkit, T. Akar, R. Burgut, and S. C. Demir, “Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species,” Medical Mycology, vol. 49, no. 1, pp. 16–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Nyirjesy, S. M. Seeney, M. H. T. Grody, C. A. Jordan, and H. R. Buckley, “Chronic fungal vaginitis: the value of cultures,” American Journal of Obstetrics and Gynecology, vol. 173, no. 3, pp. 820–823, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Singh, J. D. Sobel, P. Bhargava, D. Boikov, and J. A. Vazquez, “Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy,” Clinical Infectious Diseases, vol. 35, no. 9, pp. 1066–1070, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Nyirjesy, A. B. Alexander, and M. V. Weitz, “Vaginal Candida parapsilosis: pathogen or bystander?” Infectious Disease in Obstetrics and Gynecology, vol. 13, no. 1, pp. 37–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Pfaller, D. J. Diekema, D. L. Gibbs et al., “Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005,” Journal of Clinical Microbiology, vol. 46, no. 2, pp. 515–521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Sobel, M. Zervos, B. D. Reed et al., “Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications,” Antimicrobial Agents and Chemotherapy, vol. 47, no. 1, pp. 34–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Agatensi, F. Franchi, V. Mondello et al., “Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic,” Journal of Clinical Pathology, vol. 44, no. 10, pp. 826–830, 1991. View at Google Scholar · View at Scopus
  11. H. R. Buckley, “Identification of yeasts,” in Medical Mycology: A Practical Approach, E. G. V. Evans and M. D. Richardson, Eds., pp. 97–109, IRL Press, Oxford, UK, 1989. View at Google Scholar
  12. Clinical Laboratory Standards Institution, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard CLSI Document M27-A3, Wayne, Pa, USA, 2008.
  13. A. Kalkancı, A. B. Güzel, I. I. J. Khalil, M. Aydin, M. Ilkit, and S. Kustimur, “Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors,” Medical Mycology, vol. 50, no. 6, pp. 585–593, 2012. View at Google Scholar
  14. M. A. Pfaller, D. Andes, D. J. Diekema, A. Espinel-Ingroff, and D. Sheehan, “Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods,” Drug Resistance Updates, vol. 13, no. 6, pp. 180–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Marchaim, L. Lemanek, S. Bheemreddy, K. S. Kaye, and J. D. Sobel, “Fluconazole-resistant Candida albicans vulvovaginitis,” Obstetrics & Gynecology, vol. 120, no. 6, pp. 1407–1414, 2012. View at Google Scholar
  16. S. S. Richter, R. P. Galask, S. A. Messer, R. J. Hollis, D. J. Diekema, and M. A. Pfaller, “Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases,” Journal of Clinical Microbiology, vol. 43, no. 5, pp. 2155–2162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. G. M. Lyon, S. Karatela, S. Sunay, and Y. Adiri, “Antifungal susceptibility testing of Candida isolates from the Candida surveillance study,” Journal of Clinical Microbiology, vol. 48, no. 4, pp. 1270–1275, 2010. View at Publisher · View at Google Scholar · View at Scopus